Skip to main content
Top
Published in: Archives of Virology 1/2015

01-01-2015 | Original Article

Pathophysiology of the pancreas after oral infection of genetically diverse mice with coxsackievirus B4-E2

Authors: Jana Precechtelova, Maria Borsanyiova, Darina Stipalova, Sona Sarmirova, Pavol Gomolcak, Katarina Berakova, Shubhada Bopegamage

Published in: Archives of Virology | Issue 1/2015

Login to get access

Abstract

Coxsackievirus B4 strain E2 (CVB4-E2) and its association with type 1 diabetes (T1D) have been studied in experimental in vitro and in vivo murine models. CVB4-E2, known to be pancreotropic and diabetogenic in nature, is associated with acute pancreatitis in mice but shows differences in the induction of glycemia after intraperitoneal (i.p.) infection. Therefore, the aim of this work was to study the outcome of oral infection with CVB4-E2 in five mouse strains with different genetic backgrounds: two outbred (Swiss albino, CD1), two inbred (SJL, NOD) and one transgenic (NOD.SCID). Survival rates, fasting blood glucose, histopathology, viral titres and persistence were studied in selected organs and stool samples. Viral protein (VP1), proinflammatory cytokines, and interferon alpha (IFN-α) were analyzed by immunohistochemistry. We observed mortality only in infected NOD and NOD.SCID mice, with differing survival rates implying initial innate protection in the NOD.SCID mice and low virus clearance with replicating virus titres in the studied organs and stool up to day 40 post infection (p.i.). Independent of the mouse strain hyperglycemia, proinflammatory cytokines and histopathological changes were absent in the endocrine pancreas of infected mice. Only the pancreata of the dead NOD.SCID mice showed inflammation even in presence of IFN-α. Host-dependent viral RNA persistence was observed in all outbred mice. In conclusion, oral infection with CVB4-E2, despite the known affinity of this strain towards the pancreatic tissue and the presence of replicating virus, conferred total protection to the endocrine pancreas in all mice and failed to induce the proinflammatory cytokines studied by us.
Literature
2.
go back to reference Davydova B, Harkonen T, Kaialainen S, Hovi T, Vaarala O, Roivainen M (2003) Coxsackievirus immunization delays onset of diabetes in non-obese diabetic mice. J Med Virol 69:510–520. doi:10.1002/jmv.10339 PubMedCrossRef Davydova B, Harkonen T, Kaialainen S, Hovi T, Vaarala O, Roivainen M (2003) Coxsackievirus immunization delays onset of diabetes in non-obese diabetic mice. J Med Virol 69:510–520. doi:10.​1002/​jmv.​10339 PubMedCrossRef
3.
go back to reference de Palma AM, Verbeken E, van Aelst I, van den Steen PE, Opdenakker G, Neyts J (2008) Increased gelatinase B/matrix metalloproteinase 9 (MMP-9) activity in a murine model of acute coxsackievirus B4-induced pancreatitis. Virology 382:20–27. doi:10.1016/j.virol.2008.08.046 PubMedCrossRef de Palma AM, Verbeken E, van Aelst I, van den Steen PE, Opdenakker G, Neyts J (2008) Increased gelatinase B/matrix metalloproteinase 9 (MMP-9) activity in a murine model of acute coxsackievirus B4-induced pancreatitis. Virology 382:20–27. doi:10.​1016/​j.​virol.​2008.​08.​046 PubMedCrossRef
4.
go back to reference Flodstrom M, Horwitz MS, Maday A, Balakrishna D, Rodriguez E, Sarvetnick N (2001) A critical role for inducible nitric oxide synthase in host survival following coxsackievirus B4 infection. Virology 281:205–215. doi:10.1006/viro.2000.0801 PubMedCrossRef Flodstrom M, Horwitz MS, Maday A, Balakrishna D, Rodriguez E, Sarvetnick N (2001) A critical role for inducible nitric oxide synthase in host survival following coxsackievirus B4 infection. Virology 281:205–215. doi:10.​1006/​viro.​2000.​0801 PubMedCrossRef
5.
go back to reference Flodstrom M, Maday A, Balakrishna D, Cleary MM, Yoshimura A, Sarvetnick N (2002) Target cell defense prevents the development of diabetes after viral infection. Nat Immunol 3:373–382. doi:10.1038/ni771 PubMedCrossRef Flodstrom M, Maday A, Balakrishna D, Cleary MM, Yoshimura A, Sarvetnick N (2002) Target cell defense prevents the development of diabetes after viral infection. Nat Immunol 3:373–382. doi:10.​1038/​ni771 PubMedCrossRef
7.
go back to reference Hindersson M, Orn A, Harris RA, Frisk G (2004) Strains of coxsackie virus B4 differed in their ability to induce acute pancreatitis and the responses were negatively correlated to glucose tolerance. Arch Virol 2:1–12. doi:10.1007/s00705-004-0347-2 Hindersson M, Orn A, Harris RA, Frisk G (2004) Strains of coxsackie virus B4 differed in their ability to induce acute pancreatitis and the responses were negatively correlated to glucose tolerance. Arch Virol 2:1–12. doi:10.​1007/​s00705-004-0347-2
8.
go back to reference Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N (1998) Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 4:781–785. doi:10.1038/nm0798-781 PubMedCrossRef Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N (1998) Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 4:781–785. doi:10.​1038/​nm0798-781 PubMedCrossRef
9.
go back to reference Horwitz MS, Krahl T, Fine C, Lee J, Sarvetnick N (1999) Protection from lethal coxsackievirus-induced pancreatitis by expression of gamma interferon. J Virol 73:1756–1766PubMedCentralPubMed Horwitz MS, Krahl T, Fine C, Lee J, Sarvetnick N (1999) Protection from lethal coxsackievirus-induced pancreatitis by expression of gamma interferon. J Virol 73:1756–1766PubMedCentralPubMed
11.
go back to reference Serreze DV, Wasserfall C, Ottendorfer EW, Stalvey M, Pierce MA, Gauntt C, O’Donnell B, Flanagan JB, Campbell-Thompson M, Ellis TM, Atkinson MA (2005) Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon. J Virol 79:1045–1052. doi:10.1128/JVI.79.2.1045-1052.2005 PubMedCentralPubMedCrossRef Serreze DV, Wasserfall C, Ottendorfer EW, Stalvey M, Pierce MA, Gauntt C, O’Donnell B, Flanagan JB, Campbell-Thompson M, Ellis TM, Atkinson MA (2005) Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon. J Virol 79:1045–1052. doi:10.​1128/​JVI.​79.​2.​1045-1052.​2005 PubMedCentralPubMedCrossRef
12.
go back to reference Yap IS, Giddings G, Pocock E, Chantler JK (2003) Lack of islet neogenesis plays a key role in beta-cell depletion in mice infected with a diabetogenic variant of coxsackievirus B4. J Gen Virol 84:3051–3068. doi:10.1099/vir.0.19150-0 PubMedCrossRef Yap IS, Giddings G, Pocock E, Chantler JK (2003) Lack of islet neogenesis plays a key role in beta-cell depletion in mice infected with a diabetogenic variant of coxsackievirus B4. J Gen Virol 84:3051–3068. doi:10.​1099/​vir.​0.​19150-0 PubMedCrossRef
13.
go back to reference Yoon JW, Onodera T, Notkins A (1978) Virus-induced diabetes mellitus. XV. Beta cell damage and insulin-dependent hyperglycemia in mice infected with coxsackie virus B4. J Exp Med Sci 148:1068–1080. doi:10.1084/jem.148.4.1068 CrossRef Yoon JW, Onodera T, Notkins A (1978) Virus-induced diabetes mellitus. XV. Beta cell damage and insulin-dependent hyperglycemia in mice infected with coxsackie virus B4. J Exp Med Sci 148:1068–1080. doi:10.​1084/​jem.​148.​4.​1068 CrossRef
14.
go back to reference Roivainen M, Rasilainen S, Ylipaasto P, Nissinen R, Ustinov J, Bouwens L, Eizirik DL, Hovi T, Otonkoski T (2000) Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells. J Clin Endocrinol Metab 85:432–440. doi:10.1210/jc.85.1.432 PubMed Roivainen M, Rasilainen S, Ylipaasto P, Nissinen R, Ustinov J, Bouwens L, Eizirik DL, Hovi T, Otonkoski T (2000) Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells. J Clin Endocrinol Metab 85:432–440. doi:10.​1210/​jc.​85.​1.​432 PubMed
16.
go back to reference Bopegamage S, Borsanyiova M, Vargova A, Petrovicova A, Benkovicova M, Gomolcak P (2003) Coxsackievirus infection of mice I. Viral kinetics and histopathological changes in mice experimentally infected with coxscakievirus B3 and B4 by the oral route. Act Virol 47:245–251 Bopegamage S, Borsanyiova M, Vargova A, Petrovicova A, Benkovicova M, Gomolcak P (2003) Coxsackievirus infection of mice I. Viral kinetics and histopathological changes in mice experimentally infected with coxscakievirus B3 and B4 by the oral route. Act Virol 47:245–251
17.
go back to reference Bopegamage S, Kovacova J, Vargova A, Motusova J, Petrovicova A, Benkovicova M, Gomolcak P, Bakkers J, van Kuppeveld F, Melchers WJG, Galama JM (2005) Coxsackie B virus infection of mice: inoculation by the oral route protects the pancreas from damage, but not from infection. J Gen Virol 86:3271–3280. doi:10.1099/vir.0.81249-0 PubMedCrossRef Bopegamage S, Kovacova J, Vargova A, Motusova J, Petrovicova A, Benkovicova M, Gomolcak P, Bakkers J, van Kuppeveld F, Melchers WJG, Galama JM (2005) Coxsackie B virus infection of mice: inoculation by the oral route protects the pancreas from damage, but not from infection. J Gen Virol 86:3271–3280. doi:10.​1099/​vir.​0.​81249-0 PubMedCrossRef
18.
go back to reference Bopegamage S, Precechtelova J, Marosova L, Stipalova D, Sojka M, Borsanyiova M, Gomolcak P, Berakova K, Galama JM (2012) Outcome of challenge with Coxsackievirus B4 in young mice after maternal infection with the same virus during gestation. FEMS Immunol Med Microbiol 64:184–190. doi:10.1111/j.1574-695X.2011.00886.x PubMedCrossRef Bopegamage S, Precechtelova J, Marosova L, Stipalova D, Sojka M, Borsanyiova M, Gomolcak P, Berakova K, Galama JM (2012) Outcome of challenge with Coxsackievirus B4 in young mice after maternal infection with the same virus during gestation. FEMS Immunol Med Microbiol 64:184–190. doi:10.​1111/​j.​1574-695X.​2011.​00886.​x PubMedCrossRef
19.
go back to reference Hierholzer J, Killington RA (1996) Virus isolation and quantitation. In: Mahy BW, Kangro HO (eds) Virology methods manual. Academic Press, San Diego, pp 25–46CrossRef Hierholzer J, Killington RA (1996) Virus isolation and quantitation. In: Mahy BW, Kangro HO (eds) Virology methods manual. Academic Press, San Diego, pp 25–46CrossRef
21.
go back to reference Lehr HA, Jacobs TW, Yaziji H, Schnitt SJ, Gown AM (2001) Quantitative evaluation of HER-2/neu. Status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis. Am J Clin Pathol 115:814–822PubMedCrossRef Lehr HA, Jacobs TW, Yaziji H, Schnitt SJ, Gown AM (2001) Quantitative evaluation of HER-2/neu. Status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis. Am J Clin Pathol 115:814–822PubMedCrossRef
25.
go back to reference Hober D, Sane F, Riedweg K, Moumna I, Goffard A, Choteau L, Alidjinou KE, Desailloud R (2013) Viruses and type 1 diabetes: focus on the enteroviruses. In: Alan PE, Alice L (eds) Type 1 diabetes. InTech Publisher, p 613. ISBN 978-953-51-1017-0. doi: 10.5772/52087 Hober D, Sane F, Riedweg K, Moumna I, Goffard A, Choteau L, Alidjinou KE, Desailloud R (2013) Viruses and type 1 diabetes: focus on the enteroviruses. In: Alan PE, Alice L (eds) Type 1 diabetes. InTech Publisher, p 613. ISBN 978-953-51-1017-0. doi: 10.​5772/​52087
26.
go back to reference Jaidane H, Sané F, Gharbi J, Aouni M, Romond MB, Hober D (2009) Coxsackievirus B4 and type 1 diabetes pathogenesis: contribution of animal models. Diabetes-metab Res Rev 25:591–603. doi:10.1002/dmrr.995 PubMedCrossRef Jaidane H, Sané F, Gharbi J, Aouni M, Romond MB, Hober D (2009) Coxsackievirus B4 and type 1 diabetes pathogenesis: contribution of animal models. Diabetes-metab Res Rev 25:591–603. doi:10.​1002/​dmrr.​995 PubMedCrossRef
28.
go back to reference Serreze DV, Ottendorfer EW, Ellis TM, Gauntt CJ, Atkinson MA (2000) Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 49:708–711. doi:10.2337/diabetes.49.5.708 PubMedCrossRef Serreze DV, Ottendorfer EW, Ellis TM, Gauntt CJ, Atkinson MA (2000) Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 49:708–711. doi:10.​2337/​diabetes.​49.​5.​708 PubMedCrossRef
31.
go back to reference Schulte BM, Bakkers J, Lanke KH, Melchers WJ, Westerlaken C, Allebes W, Aanstoot HJ, Bruining GJ, Adema GJ, van Kuppeveld FJ, Galama JM (2010) Detection of enterovirus RNA in peripheral blood mononuclear cells of type 1 diabetic patients beyond the stage of acute infection. Viral Immunol 23:99–104. doi:10.1089/vim.2009.0072 PubMedCrossRef Schulte BM, Bakkers J, Lanke KH, Melchers WJ, Westerlaken C, Allebes W, Aanstoot HJ, Bruining GJ, Adema GJ, van Kuppeveld FJ, Galama JM (2010) Detection of enterovirus RNA in peripheral blood mononuclear cells of type 1 diabetic patients beyond the stage of acute infection. Viral Immunol 23:99–104. doi:10.​1089/​vim.​2009.​0072 PubMedCrossRef
32.
33.
go back to reference Ylipaasto P, Smura T, Gopalacharyulu P, Paananen A, Seppanen-Laakso T, Kaijalainen S, Ahlfors H, Korsgren O, Lakey JR, Lahesmaa R, Piemonti L, Oresic M, Galama J, Roivainen M (2012) Enterovirus-induced gene expression profile is critical for human pancreatic islet destruction. Diabetologia 55:3273–3283. doi:10.1007/s00125-012-2713-z PubMedCrossRef Ylipaasto P, Smura T, Gopalacharyulu P, Paananen A, Seppanen-Laakso T, Kaijalainen S, Ahlfors H, Korsgren O, Lakey JR, Lahesmaa R, Piemonti L, Oresic M, Galama J, Roivainen M (2012) Enterovirus-induced gene expression profile is critical for human pancreatic islet destruction. Diabetologia 55:3273–3283. doi:10.​1007/​s00125-012-2713-z PubMedCrossRef
34.
go back to reference Anagandula M, Richardson SJ, Oberste MS, Sioofy-Khojine A, Hyoty H, Morgan NG, Korsgren O, Frisk G (2014) Infection of human islets of langerhans with two strains of coxsackie B virus serotype 1: assessment of virus replication, degree of cell death and induction of genes involved in the innate immunity pathway. J Med Virol 86:1402–1411. doi:10.1002/jmv.23835 PubMed Anagandula M, Richardson SJ, Oberste MS, Sioofy-Khojine A, Hyoty H, Morgan NG, Korsgren O, Frisk G (2014) Infection of human islets of langerhans with two strains of coxsackie B virus serotype 1: assessment of virus replication, degree of cell death and induction of genes involved in the innate immunity pathway. J Med Virol 86:1402–1411. doi:10.​1002/​jmv.​23835 PubMed
Metadata
Title
Pathophysiology of the pancreas after oral infection of genetically diverse mice with coxsackievirus B4-E2
Authors
Jana Precechtelova
Maria Borsanyiova
Darina Stipalova
Sona Sarmirova
Pavol Gomolcak
Katarina Berakova
Shubhada Bopegamage
Publication date
01-01-2015
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 1/2015
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-014-2236-7

Other articles of this Issue 1/2015

Archives of Virology 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.